CompanyGraph
What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleRevenue is $1.29B, above the global median of $548.88M
- PositionGross margin is 37.2%, higher than 95% of its Pharmaceutical Retailers peers (median 25.6%)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
8.03%Above 5Y avg (4.09%)
Annual Rate
CNY 1.27Paid annual
Payout Ratio
144.3%High
Payback Period
12.6 yr
Last Ex-Dividend
Jun 12, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.44BCNY363.71M · vs all stocks (USD)
Trailing P/E
17.34xvs Pharmaceutical Retailers peers
Revenue (TTM)
8.65BCNY1.29B · vs all stocks (USD)
Profit Margin
1.50%vs Pharmaceutical Retailers peers
Beta
0.5210xvs all stocks
52-Week Change
-23.90%vs all stocks
Market Capitalization
2.44BCNY363.71M · vs all stocks (USD)
Enterprise Value
5.50BCNY820.93M · vs all stocks (USD)
Trailing P/E
17.34xvs Pharmaceutical Retailers peers
Price to Sales (TTM)
0.2727xvs Pharmaceutical Retailers peers
Price to Book (MRQ)
0.8909xvs Pharmaceutical Retailers peers
Enterprise to Revenue
0.6360xvs Pharmaceutical Retailers peers
Enterprise to EBITDA
13.09xvs Pharmaceutical Retailers peers
Gross Margin
37.15%vs Pharmaceutical Retailers peers
Profit Margin
1.50%vs Pharmaceutical Retailers peers
Operating Margin
2.95%vs Pharmaceutical Retailers peers
Return on Assets (TTM)
2.31%vs Pharmaceutical Retailers peers
Return on Equity (TTM)
5.04%vs Pharmaceutical Retailers peers
Revenue (TTM)
8.65BCNY1.29B · vs all stocks (USD)
Revenue per Share (TTM)
58.51CNYUpdated Sep 22, 2026Quarterly Revenue Growth
-3.30%vs Pharmaceutical Retailers peers
Gross Profit (TTM)
3.13BCNY467.51M · vs all stocks (USD)
EBITDA (TTM)
1.22BCNY182.04M · vs all stocks (USD)
Net Income (TTM)
129.42MCNY19.33M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-54.40%vs Pharmaceutical Retailers peers
Operating Cash Flow (TTM)
1.21BCNY181.27M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.19BCNY178.01M · vs all stocks (USD)
Trailing Annual Dividend Rate
1.27CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
8.03%vs all stocks
5-Year Average Dividend Yield
4.09%vs all stocks
Payout Ratio
144.32%vs Pharmaceutical Retailers peers
Minority Interest (Equity)
-1.31MCNYFY2025 · Dec 31, 2025Revenue
8.92BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
5.70BCNYFY2025 · Dec 31, 2025Gross Profit
3.22BCNYFY2025 · Dec 31, 2025Operating Income
425.65MCNY63.56M · vs all stocks (USD)
Pre-tax Income
207.16MCNYFY2025 · Dec 31, 2025Income Tax Expense
59.04MCNYFY2025 · Dec 31, 2025Net Income
148.12MCNYFY2025 · Dec 31, 2025EBIT
327.88MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.22BCNYFY2025 · Dec 31, 2025Selling, General & Administrative
658.39MCNYFY2025 · Dec 31, 2025Other Operating Expenses
38.76MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
3.36MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
120.72MCNYFY2025 · Dec 31, 2025EPS (Basic)
1.00CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.00CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
148.15MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
148.15MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
148.12MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
33.44KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
786.15MCNYFY2025 · Dec 31, 2025Free Cash Flow
665.74MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
301.87MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
148.12MCNYFY2025 · Dec 31, 2025Other Non-cash Items
283.00MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-623.75MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
978.78MCNYFY2025 · Dec 31, 2025Capital Expenditures
-120.40MCNYFY2025 · Dec 31, 2025Purchase of Investments
-51.39MCNYFY2025 · Dec 31, 2025Sale of Investments
100.50MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-71.29MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.32BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.29BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-242.90MCNYFY2025 · Dec 31, 2025Other Financing Charges
-784.14MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-997.31MCNYFY2025 · Dec 31, 2025Shares Outstanding
154.54MSharesUpdated Sep 22, 2026Float Shares
66.84MSharesUpdated Sep 22, 2026% Held by Insiders
54.43%vs all stocks
% Held by Institutions
4.84%vs all stocks
Total Cash (MRQ)
870.83MCNY130.04M · vs all stocks (USD)
Total Cash per Share (MRQ)
5.88CNYUpdated Sep 22, 2026Total Debt (MRQ)
4.11BCNY613.56M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.62xvs Pharmaceutical Retailers peers
Current Ratio (MRQ)
0.7640xvs Pharmaceutical Retailers peers
Book Value per Share (MRQ)
17.13CNYUpdated Sep 22, 2026Total Assets
9.75BCNY1.46B · vs all stocks (USD)
Total Current Assets
4.33BCNYFY2025 · Dec 31, 2025Total Liabilities
7.08BCNYFY2025 · Dec 31, 2025Total Non-current Assets
5.42BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.70BCNYFY2025 · Dec 31, 2025Total Current Liabilities
5.38BCNYFY2025 · Dec 31, 2025Cash
275.03MCNYFY2025 · Dec 31, 2025Cash Equivalents
603.55MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
878.58MCNYFY2025 · Dec 31, 2025Accounts Receivable
1.06BCNYFY2025 · Dec 31, 2025Inventory
2.11BCNYFY2025 · Dec 31, 2025Accounts Payable
2.25BCNYFY2025 · Dec 31, 2025Short-term Debt
2.80BCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.33MCNYFY2025 · Dec 31, 2025Long-term Debt
1.48BCNYFY2025 · Dec 31, 2025Common Stock (Book)
154.54MCNYFY2025 · Dec 31, 2025Retained Earnings
1.17BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.67BCNY398.96M · vs all stocks (USD)
Treasury Stock
145.44MCNYFY2025 · Dec 31, 202552-Week Low
14.41CNYUpdated Sep 22, 202652-Week High
22.30CNYUpdated Sep 22, 202652-Week Change
-23.90%vs all stocks
Beta
0.5210xvs all stocks
50-Day MA
16.26CNYUpdated Sep 22, 2026200-Day MA
18.36CNYUpdated Sep 22, 2026Avg 10-Day Volume
1.39MSharesUpdated Sep 22, 2026Avg 30-Day Volume
2.02MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.8800CNYUpdated Sep 22, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 37.2%, higher than 95% of its Pharmaceutical Retailers peers (median 25.6%)Significant
Gross margin: 0.37Industry median: 0.26Industry P95: 0.36Peers compared: 21.00
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 1.44Dividend per Share: 1.27Earnings per Share: 0.88
Financial Health
Altman Z-Score 1.27: grey zoneSignificant
Altman Z-Score: 1.27
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Revenue is $1.29B, above the global median of $548.88MNotable
Revenue (USD): 1,291,299,794.196Global Median: 548,883,780.48
Levered free cash flow is $178.01M, above the global median of $18.73MNotable
Levered free cash flow (USD): 178,010,802.435Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Retail Partners Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceRisk
Shanghai No.1 Pharmacy Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceRule
Shoe Carnival Inc.
Tier 1FlowUnit ReplicationRiskInterface
Genesco Inc.
Tier 1FlowUnit ReplicationRiskInterface
Vertu Motors plc
Tier 1FlowUnit ReplicationInterfaceRisk
Sichuan Hezong Medicine Co., Ltd.
Tier 1FlowUnit ReplicationProductionInterface
VT Holdings Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceRisk
PTG Energy Public Company Limited
Tier 1FlowUnit ReplicationInterfaceProduction
Ministop Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
G-7 Holdings Inc.
Tier 1FlowUnit ReplicationInterfaceProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
Hangzhou Huawang New Materials Co., Ltd.
1 interpretationClose Below 40W SMA With Profitability
Shutterstock Inc.
1 interpretationClose Below 40W SMA With Profitability
Future plc
1 interpretationClose Below 40W SMA With Profitability